U.S. patent application number 16/789671 was filed with the patent office on 2020-06-11 for systems and methods for treating a tissue site with reduced pressure involving a reduced-pressure interface having a multi-lumen.
The applicant listed for this patent is KCI Licensing, Inc.. Invention is credited to Christopher Brian LOCKE, Aidan Marcus TOUT.
Application Number | 20200179581 16/789671 |
Document ID | / |
Family ID | 46584414 |
Filed Date | 2020-06-11 |
![](/patent/app/20200179581/US20200179581A1-20200611-D00000.png)
![](/patent/app/20200179581/US20200179581A1-20200611-D00001.png)
![](/patent/app/20200179581/US20200179581A1-20200611-D00002.png)
![](/patent/app/20200179581/US20200179581A1-20200611-D00003.png)
![](/patent/app/20200179581/US20200179581A1-20200611-D00004.png)
![](/patent/app/20200179581/US20200179581A1-20200611-D00005.png)
![](/patent/app/20200179581/US20200179581A1-20200611-D00006.png)
![](/patent/app/20200179581/US20200179581A1-20200611-D00007.png)
![](/patent/app/20200179581/US20200179581A1-20200611-D00008.png)
![](/patent/app/20200179581/US20200179581A1-20200611-D00009.png)
![](/patent/app/20200179581/US20200179581A1-20200611-D00010.png)
United States Patent
Application |
20200179581 |
Kind Code |
A1 |
TOUT; Aidan Marcus ; et
al. |
June 11, 2020 |
Systems And Methods For Treating A Tissue Site With Reduced
Pressure Involving A Reduced-Pressure Interface Having A
Multi-Lumen Conduit For Contacting A Manifold
Abstract
Systems and methods for a reduced-pressure interface for
connecting a multi-lumen conduit to a distribution manifold. The
interface includes a housing having a flange portion and a cavity
wall portion. The cavity wall portion forms a cavity having a
tissue-facing cavity opening. The interface further includes an
attachment device, a conduit port, and a multi-lumen conduit. The
attachment device is coupled to a tissue-facing side of the flange
portion for coupling the housing to a sealing member. The conduit
includes a distal end and a proximal whereby the distal end extends
through a conduit aperture and past the cavity wall portion into
the cavity. The conduit further includes a primary lumen and a
plurality of sensing lumens. The primary lumen and the plurality of
sensing lumens extend from the proximal end of the conduit to the
distal end. The conduit is adapted to contact the distribution
manifold.
Inventors: |
TOUT; Aidan Marcus;
(Alderbury, GB) ; LOCKE; Christopher Brian;
(Bournemouth, GB) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
KCI Licensing, Inc. |
San Antonio |
TX |
US |
|
|
Family ID: |
46584414 |
Appl. No.: |
16/789671 |
Filed: |
February 13, 2020 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
15657989 |
Jul 24, 2017 |
|
|
|
16789671 |
|
|
|
|
14678698 |
Apr 3, 2015 |
9750857 |
|
|
15657989 |
|
|
|
|
13554542 |
Jul 20, 2012 |
9023012 |
|
|
14678698 |
|
|
|
|
61511827 |
Jul 26, 2011 |
|
|
|
61511840 |
Jul 26, 2011 |
|
|
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
A61F 2013/00174
20130101; A61M 25/00 20130101; A61M 1/0088 20130101; A61F 13/00068
20130101; A61M 1/0025 20140204; A61M 1/00 20130101; A61F 2013/00536
20130101; A61M 2205/3344 20130101; A61F 2013/0054 20130101 |
International
Class: |
A61M 1/00 20060101
A61M001/00; A61M 25/00 20060101 A61M025/00; A61F 13/00 20060101
A61F013/00 |
Claims
1. A reduced-pressure connection, comprising: a distribution
manifold for placing proximate to a tissue site; a housing of
semi-rigid material; a conduit having a distal end and comprising
at least one sensing lumen and at least one primary lumen; and
wherein the distal end of the conduit is configured to be drawn
into direct contact with the distribution manifold.
2. The reduced-pressure connection of claim 1, wherein the at least
one sensing lumen is a plurality of sensing lumens, and wherein a
plurality of distal openings are associated with the plurality of
sensing lumens on the distal end of the conduit.
3. The reduced-pressure connection of claim 2, wherein the distal
end of the conduit is in direct contact with the distribution
manifold such that a majority of the plurality of distal openings
abut the distribution manifold.
4. The reduced-pressure connection of claim 1, wherein the
semi-rigid material is selected from the group consisting of a
plasticized polyvinyl chloride, polyurethane, cyclic olefin
copolymer elastomer, thermoplastic elastomer, poly acrylic,
silicone polymer, and polyether block amide copolymer.
5. A reduced-pressure interface, comprising: a housing forming a
cavity adapted to collapse under reduced pressure; a conduit port
coupled to the housing for receiving a conduit comprising at least
one sensing lumen configured to be drawn into contact with a
manifold; and an attachment device for coupling the
reduced-pressure interface to a sealing member.
6. The reduced-pressure interface of claim 5, wherein the housing
comprises a semi-rigid material.
7. The reduced-pressure interface of claim 6, wherein the
semi-rigid material is selected from the group consisting of a
plasticized polyvinyl chloride, polyurethane, cyclic olefin
copolymer elastomer, thermoplastic elastomer, poly acrylic,
silicone polymer, and polyether block amide copolymer.
8. The reduced-pressure interface of claim 5, wherein the conduit
comprises a primary lumen for delivering reduced pressure and at
least one sensing lumen.
9. The reduced-pressure interface of claim 8, wherein the conduit
comprises a multi-lumen conduit.
Description
RELATED APPLICATIONS
[0001] The present application is a continuation of U.S. patent
application Ser. No. 15/657,989, entitled "Systems and Methods for
Treating a Tissue Site with Reduced Pressure Involving a
Reduced-Pressure Interface Having a Multi-Lumen Conduit for
Contacting a Manifold," filed Jul. 24, 2017, which is a
continuation of U.S. patent application Ser. No. 14/678,698,
entitled "Systems and Methods for Treating a Tissue Site with
Reduced Pressure Involving a Reduced-Pressure Interface Having a
Multi-Lumen Conduit for Contacting a Manifold," filed Apr. 3, 2015,
now U.S. Pat. No. 9,750,857, which is a continuation of U.S. patent
application Ser. No. 13/554,542, entitled "Systems and Methods for
Treating a Tissue Site with Reduced Pressure Involving a
Reduced-Pressure Interface Having a Multi-Lumen Conduit for
Contacting a Manifold," filed Jul. 20, 2012, now U.S. Pat. No.
9,023,012, which claims the benefit, under 35 USC .sctn. 119(e), of
the filing of U.S. Provisional Patent Application No. 61/511,840,
entitled "Systems and Methods for Treating a Tissue Site with
Reduced Pressure Involving a Reduced-Pressure Interface Having a
Cutting Element," filed Jul. 26, 2011, and U.S. Provisional Patent
Application No. 61/511,827, entitled "Systems and Methods for
Treating a Tissue Site with Reduced Pressure Involving a
Reduced-Pressure Interface Having a Multi-Lumen Conduit for
Contacting a Manifold," filed Jul. 26, 2011, which is incorporated
herein by reference for all purposes.
BACKGROUND
[0002] The present disclosure relates generally to medical
treatment systems and, more particularly, but not by way of
limitation, to systems, methods, and apparatuses for treating a
tissue site with reduced pressure involving a reduced-pressure
interface having a multi-lumen conduit for contacting a
manifold.
[0003] Clinical studies and practice have shown that providing a
reduced pressure in proximity to a tissue site augments and
accelerates the growth of new tissue at the tissue site. The
applications of this phenomenon are numerous, but application of
reduced pressure has been particularly successful in treating
wounds. This treatment (frequently referred to in the medical
community as "negative pressure wound therapy," "reduced pressure
therapy," or "vacuum therapy") provides a number of benefits, which
may include faster healing and increased formulation of granulation
tissue. Typically, reduced pressure is applied to tissue through a
manifold device, such as a porous pad. The porous pad contains
cells or pores that distribute reduced pressure to the tissue and
channel fluids that are drawn from the tissue.
SUMMARY
[0004] According to an illustrative embodiment a reduced-pressure
interface for connecting a multi-lumen conduit to a distribution
manifold is presented. The reduced-pressure interface includes a
multi-lumen conduit that abuts, at least in part, a distribution
manifold. The distribution manifold contacts at least some distal
apertures that open into sensing lumens in the multi-lumen conduit.
The distribution manifold may thereby protect those openings from
liquids entering that might block the sensing lumens.
[0005] According to another illustrative embodiment, a system for
treating a tissue site on a patient with reduced pressure includes
a distribution manifold for placing proximate to the tissue site, a
sealing member for covering the distribution manifold and a portion
of intact epidermis of the patient to form a sealed space, a
reduced-pressure interface for providing reduced pressure through
the sealing member to the distribution manifold, a reduced-pressure
source, and a multi-lumen conduit for fluidly coupling the
reduced-pressure source to the reduced-pressure interface. The
reduced-pressure interface includes a housing having a cavity wall
portion. The cavity wall portion forms a cavity having a
tissue-facing cavity opening. The reduced-pressure interface
further includes an attachment device coupled to the housing for
coupling the housing to the sealing member, a conduit port coupled
to the cavity wall and having a conduit aperture, and a multi-lumen
conduit. The multi-lumen conduit has a distal end and a proximal
end. The distal end of the multi-lumen conduit extends through the
conduit aperture into the cavity. The multi-lumen conduit further
includes at least one primary lumen for delivering reduced pressure
and a plurality of sensing lumens. The primary lumen and the
plurality of sensing lumens extend from the distal end of the
multi-lumen conduit towards the proximal end of the multi-lumen
conduit. The plurality of sensing lumens have a corresponding
plurality of distal openings at the distal end of the multi-lumen
conduit. At least one of the plurality of distal openings of the
plurality of sensing lumens contacts the distribution manifold.
[0006] The reduced-pressure interface allows the sensing lumens not
to become blocked. This is because the distribution manifold is
against at least one of the distal apertures and helps protect the
sensing lumen from liquid entry. The reduced-pressure interface may
also avoid spraying or an aerosol effect of liquids from the tissue
site that might otherwise enter a sensing lumen.
[0007] According to another illustrative embodiment, a method for
treating a tissue site on a patient with reduced pressure includes
disposing a distribution manifold proximate to the tissue site and
covering the distribution manifold and a portion of intact
epidermis of the patient with a sealing member to form a sealed
space in which the distribution manifold is disposed. The sealing
member has a first side and a second, tissue-facing side. The
method further includes providing a reduced-pressure source,
providing a multi-lumen conduit having a distal end and a proximal
end. The multi-lumen conduit includes a plurality of sensing lumens
and at least one primary lumen. The method further includes fluidly
coupling a distal end of the multi-lumen conduit to the sealed
space and disposing at least one distal opening of a plurality of
distal openings of the plurality of sensing lumens in contact with
the distribution manifold. The method also includes delivering
reduced pressure to the multi-lumen conduit.
[0008] According to another illustrative embodiment, a
reduced-pressure connection for providing reduced pressure to a
tissue site in a sealed space formed by a sealing member includes a
distribution manifold for placing proximate to the tissue site and
a multi-lumen conduit. The distribution manifold includes a foam
member. The multi-lumen conduit has a plurality of sensing lumens
and at least one primary lumen. A plurality of distal opening are
associated with the plurality of sensing lumens on a distal end of
the multi-lumen conduit. The distal end of the multi-lumen conduit
is in direct contact with the distribution manifold such that at
least one of the plurality of distal apertures abuts the
distribution manifold.
[0009] According to another illustrative embodiment, a reduced
pressure treatment system for treating a wound on a patient with
reduced pressure includes a manifold for positioning adjacent to
the wound, a drape for covering the manifold and a portion of
intact epidermis of the patient to form a sealed space, a
reduced-pressure interface for providing reduced pressure through
the drape to the manifold, a reduced-pressure source, and a first
conduit and a second conduit for fluidly coupling the
reduced-pressure source to the reduced-pressure interface. The
reduced-pressure interface includes a housing having a cavity wall
portion that forms a cavity having a tissue-facing cavity opening,
an attachment device coupled to the housing for coupling the
housing to the drape, a conduit port coupled to the cavity wall and
having a conduit aperture, and the first conduit and the second
conduit. The first conduit and the second conduit have a distal end
and a proximal end, such that the distal end extends through the
conduit aperture into the cavity. The first conduit further
includes at least one primary lumen for delivering reduced pressure
such that the primary lumen extends from the distal end to the
proximal end of the first conduit. The second conduit further
includes a plurality of sensing lumens extending from the distal
end to the proximal end of the second conduit. The plurality of
sensing lumens have a corresponding plurality of distal openings at
the distal end of the second conduit, and at least one of the
plurality of distal openings of the plurality of sensing lumens
contacts the manifold.
[0010] According to yet another illustrative embodiment, a method
for treating a wound on a patient with reduced pressure includes
positioning a manifold adjacent to the wound and covering the
manifold and a portion of intact epidermis of the patient with a
drape to form a sealed space. The drape has a first side and a
second, tissue-facing side. The method further includes providing a
reduced-pressure source and providing a first conduit and a second
conduit. The first conduit and the second conduit have a distal end
and a proximal end. The second conduit further includes a plurality
of sensing lumens. The first conduit further includes at least one
reduced-pressure lumen. The method further includes fluidly
coupling the distal end of the first conduit and the second conduit
to the drape, disposing at least one distal opening of a plurality
of distal openings of the plurality of sensing lumens in contact
with the manifold, and delivering reduced pressure to the first
conduit.
[0011] According to another illustrative embodiment, a
reduced-pressure connection for providing reduced pressure to a
wound in a sealed space formed by a drape includes a manifold for
placing proximate to the wound. The manifold includes a foam
member. The connection further includes a first conduit having at
least one primary lumen such that the first conduit has a distal
end and a second conduit having a plurality of sensing lumens such
that a plurality of distal opening are associated with the
plurality of sensing lumens on a distal end of the second conduit.
The distal end of the first and second conduits are in direct
contact with the manifold such that at least one of the plurality
of distal apertures abuts the manifold.
[0012] Other features and advantages of the illustrative
embodiments will become apparent with reference to the drawings and
detailed description that follow.
BRIEF DESCRIPTION OF THE DRAWINGS
[0013] FIG. 1 is a schematic perspective view of an illustrative
embodiment of a system for treating a tissue site with reduced
pressure;
[0014] FIG. 2 is a schematic, cross-sectional view of an
illustrative embodiment of a multi-lumen conduit of the system
shown in FIG. 1 taken along line 2-2;
[0015] FIG. 3A is a schematic, cross-sectional view of an
illustrative embodiment of a reduced-pressure interface having a
multi-lumen conduit extending into a cavity of the reduced-pressure
interface;
[0016] FIG. 3B is a schematic, cross-sectional view of the
reduced-pressure interface of FIG. 3A under reduced pressure with a
distribution manifold contacting the multi-lumen conduit;
[0017] FIG. 4 is a schematic, top perspective view of another
illustrative embodiment of a reduced-pressure interface having a
multi-lumen conduit extending into a cavity of the reduced-pressure
interface;
[0018] FIG. 5A is a schematic, cross-sectional view of the
reduced-pressure interface of FIG. 4 as applied to a tissue
site;
[0019] FIG. 5B is a schematic, cross-sectional view of the
reduced-pressure interface of FIG. 5A under reduced pressure such
that the distribution manifold contacts the multi-lumen
conduit;
[0020] FIG. 6 is a schematic, cross-sectional view of one
illustrative embodiment of a reduced-pressure interface having a
cutting element for use as part of a system for treating a tissue
site with reduced pressure;
[0021] FIG. 7A is a schematic, cross-sectional view of the
reduced-pressure interface of FIG. 6 under reduced pressure but
prior to the cutting element perforating a sealing member;
[0022] FIG. 7B is another schematic, cross-sectional view of the
reduced-pressure interface of FIG. 6 under reduced pressure after
the cutting member has perforated the sealing member;
[0023] FIG. 7C is another schematic, cross-sectional view of the
reduced-pressure interface of FIG. 6 under reduced pressure after
the cutting member has perforated the sealing member and the
cutting element has been removed;
[0024] FIG. 8 is a schematic, cross-sectional view of another
illustrative embodiment of a reduced-pressure interface having a
cutting element for use as part of a system for treating a tissue
site with reduced pressure;
[0025] FIG. 9A is a schematic, cross-sectional view of the
reduced-pressure interface of FIG. 8 being applied on a patient,
but prior to reduced pressure being supplied;
[0026] FIG. 9B is a schematic, cross-sectional view of the
reduced-pressure interface of FIG. 8 under reduced pressure prior
to the cutting element perforating a sealing member; and
[0027] FIG. 9C is a schematic, cross-sectional view of the
reduced-pressure interface of FIG. 8 under reduced pressure after
the cutting member has perforated the sealing member and the
cutting element has been removed.
DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS
[0028] In the following detailed description of the illustrative
embodiments, reference is made to the accompanying drawings that
form a part hereof. These embodiments are described in sufficient
detail to enable those skilled in the art to practice the
invention, and it is understood that other embodiments may be
utilized and that logical, structural, mechanical, electrical, and
chemical changes may be made without departing from the spirit or
scope of the invention. To avoid detail not necessary to enable
those skilled in the art to practice the embodiments described
herein, the description may omit certain information known to those
skilled in the art. The following detailed description is,
therefore, not to be taken in a limiting sense, and the scope of
the illustrative embodiments are defined only by the appended
claims. Unless otherwise indicated, as used herein, "or" does not
require mutual exclusivity.
[0029] The term "reduced pressure" as used herein generally refers
to a pressure less than the ambient pressure at a tissue site that
is being subjected to treatment. In most cases, this reduced
pressure will be less than the atmospheric pressure at which the
patient is located. Alternatively, the reduced pressure may be less
than a hydrostatic pressure associated with tissue at the tissue
site. Unless otherwise indicated, quantitative values of pressure
stated herein are gauge pressures. Reference to increases in
reduced pressure typically refer to a decrease in absolute
pressure, and decreases in reduced pressure typically refer to an
increase in absolute pressure.
[0030] Referring now to the drawings and initially to FIGS. 1-3B, a
system 100 for treating a tissue site 102 on a patient 104 with
reduced pressure is presented. The system 100 includes a
reduced-pressure dressing 106 for disposing proximate the tissue
site 102. The system includes a reduced-pressure interface 116 that
fluidly couples a multi-lumen conduit 110 to a distribution
manifold 112. The reduced-pressure interface 116 may allow for an
easily manufactured connection that allows at least one of a
plurality of sensing lumens 122 within the multi-lumen conduit 110
to remain open or unblocked during operation. During operation, the
sensing lumens 122 may remain unblocked by a distal end 118 of the
multi-lumen conduit 110 being against (or abutting) or embedded in
the distribution manifold 112 such that at least one distal
aperture on the distal end 118 of the multi-lumen conduit 110 is in
contact with the distribution manifold 112. This in turn avoids an
open area where liquids may spray, foam, or otherwise travel
towards the distal apertures and also offers a filter member in
front of the distal apertures.
[0031] The system 100 also includes a reduced-pressure treatment
unit 108 fluidly connected to the reduced-pressure dressing 106
through the multi-lumen conduit 110 for applying reduced pressure
to the tissue site 102. The reduced-pressure dressing 106 further
includes the distribution manifold 112, a sealing member 114, and
the reduced-pressure interface 116. The reduced-pressure interface
116 is adapted to connect to the multi-lumen conduit 110. The
multi-lumen conduit 110 has the distal end 118 and includes at
least one primary lumen 120 and the sensing lumens 122. While
usually there will be only one primary lumen 120, there could be
additional larger lumens for transporting the reduced pressure to
the tissue site 102 and concomitantly removing any fluids. The
distal end 118 of the multi-lumen conduit 110 is adapted to extend
into the reduced-pressure interface 116 and, at least partially,
contact the distribution manifold 112. The multi-lumen conduit 110
may either abut or be embedded within the distribution manifold
112.
[0032] Extending the multi-lumen conduit 110 into the
reduced-pressure interface 116 to promote contact between the
distal end 118 of the multi-lumen conduit 110 and the distribution
manifold 112 may, in addition to those previously mentioned,
provide a number of benefits. The benefits may include ease of
application, reduction of error when forming a seal between the
multi-lumen conduit 110 and the distribution manifold 112, and
reduction in instances of sensing lumen occlusion when fluid is
removed from the tissue site 102. Instances where the sensing
lumens 122 become occluded may disconnect the system's 100 ability
to monitor levels of reduced pressure, and thus, control the
reduced pressure at the tissue site 102.
[0033] Fluid removed from the tissue site 102 will follow the path
of least resistance which preferentially is the primary lumen 120.
When the primary lumen 120 and at least one of the sensing lumens
122 are not in direct contact with the manifold, the fluid may
splash, foam, or otherwise fail to smoothly transition into the
primary lumen 120. When the fluid splashes or foams, the fluid may
enter the sensing lumens 122 occluding the sensing lumens 122.
Should all of the sensing lumens 122 become occluded, the sensing
lumens 122 are effectively disabled from sensing the reduced
pressure levels at the tissue site 102. When the primary lumen 120
and at least one of the sensing lumens 122 are in contact with the
distribution manifold 112, the fluid withdrawn from the tissue site
102 tends to bypass entering the sensing lumens 122 contacting the
distribution manifold 112 and flow into the primary lumen 120. The
distribution manifold 112 may further provide a barrier between the
primary lumen 120 and the at least one of the plurality of sensing
lumens 122 contacting the distribution manifold 112. Additionally,
having the multi-lumen conduit 110 in direct contact with the
distribution manifold 112 may help ensure that there is a constant
low velocity liquid flow into the multi-lumen conduit 110 which may
minimize the instance of aerosolized particles being deposited
around the at least one sensing lumen 122 contacting the
distribution manifold 112 and may also provide a filter to liquids
entering the at least one sensing lumen 122.
[0034] In prior reduced pressure treatment systems using a reduced
pressure interface and a multi-lumen conduit, the reduced pressure
interfaces have been designed to remove the sensory lumens from
direct contact with the distribution manifold to inhibit fluid from
occluding the sensory lumens. However, testing has shown that
removing the sensory lumens from contacting the distribution
manifold creates splashing and foaming that may occlude the sensory
lumens undermining the purpose of removing the sensory lumens from
contacting the distribution manifold.
[0035] The system 100 may be used with various different types of
tissue sites 102. The tissue site 102 may be a wound 124 or wound
cavity. As shown in at least FIGS. 3A-3B, the tissue site 102 or
the wound 124, may be through an epidermis 126 and into a
subcutaneous tissue or any other tissue. The tissue site 102 may be
the bodily tissue of any human, animal, or other organism,
including bone tissue, adipose tissue, muscle tissue, dermal
tissue, vascular tissue, connective tissue, cartilage, tendons,
ligaments, body cavity or any other tissue. Treatment of the tissue
site 102 may include removal of fluids, e.g., exudate or
ascites.
[0036] Referring still to FIGS. 1-3B, the distribution manifold 112
is proximate the tissue site 102 and has a first side 128 and a
second, tissue-facing side 130. The term "distribution manifold" as
used herein generally refers to a substance or structure that is
provided to assist in applying reduced pressure to, delivering
fluids to, or removing fluids from the tissue site 102. The
distribution manifold 112 typically includes a plurality of flow
channels or pathways that distribute fluids provided to and removed
from the tissue site 102 around the distribution manifold 112. In
one illustrative embodiment, the flow channels or pathways are
interconnected to improve distribution of fluids provided or
removed from the tissue site 102. The distribution manifold 112 may
be a biocompatible material that is capable of being placed in
contact with the tissue site 102 and distributing reduced pressure
to the tissue site 102. Examples of the distribution manifold 112
may include, without limitation, devices that have structural
elements arranged to form flow channels, such as, for example,
cellular foam, open-cell foam, porous tissue collections, liquids,
gels, and foams that include, or cure to include, flow channels.
The distribution manifold 112 may be porous and may be made from
foam, gauze, felted mat, or any other material suited to a
particular biological application. In one embodiment, the
distribution manifold 112 is a porous foam and includes a plurality
of interconnected cells or pores that act as flow channels. The
porous foam may be a polyurethane, open-cell, reticulated foam such
as GranuFoam.RTM. material manufactured by Kinetic Concepts,
Incorporated of San Antonio, Tex. In some situations, the
distribution manifold 112 may also be used to distribute fluids
such as medications, antibacterials, growth factors, and various
solutions to the tissue site 102. Other layers may be included in
or on the distribution manifold 112, such as absorptive materials,
wicking materials, hydrophobic materials, and hydrophilic
materials.
[0037] In one illustrative embodiment, the distribution manifold
112 may be constructed from bioresorbable materials that do not
have to be removed from a patient's body following use of the
system 100. Suitable bioresorbable materials may include, without
limitation, a polymeric blend of polylactic acid (PLA) and
polyglycolic acid (PGA). The polymeric blend may also include
without limitation polycarbonates, polyfumarates, and
capralactones. The distribution manifold 112 may further serve as a
scaffold for new cell-growth, or a scaffold material may be used in
conjunction with the distribution manifold 112 to promote
cell-growth. A scaffold is a substance or structure used to enhance
or promote the growth of cells or formation of tissue, such as a
three-dimensional porous structure that provides a template for
cell growth. Illustrative examples of scaffold materials include
calcium phosphate, collagen, PLA/PGA, coral hydroxy apatites,
carbonates, or processed allograft materials.
[0038] The distribution manifold 112 may be covered by the sealing
member 114, which may also be referred to as a drape. The sealing
member 114 forms a sealed space 132 over the tissue site 102. The
sealing member 114 has a first side 134, and a second,
tissue-facing side 136. The sealing member 114 may be any material
that provides a fluid seal. "Fluid seal," or "seal," means a seal
adequate to maintain reduced pressure at a desired site given the
particular reduced-pressure source or subsystem involved. The
sealing member 114 may, for example, be an impermeable or
semi-permeable, elastomeric material. "Elastomeric" means having
the properties of an elastomer. Elastomer generally refers to a
polymeric material that has rubber-like properties. More
specifically, most elastomers have ultimate elongations greater
than 100% and a significant amount of resilience. The resilience of
a material refers to the material's ability to recover from an
elastic deformation. Elastomers that are relatively less resilient
may also be used as these elastomers are more likely to tear when
faced with the cutting element. Examples of elastomers may include,
but are not limited to, natural rubbers, polyisoprene, styrene
butadiene rubber, chloroprene rubber, polybutadiene, nitrile
rubber, butyl rubber, ethylene propylene rubber, ethylene propylene
diene monomer, chlorosulfonated polyethylene, polysulfide rubber,
polyurethane (PU), EVA film, co-polyester, and silicones.
Additional, specific examples of dressing sealing member materials
include a silicone drape, 3M Tegaderm.RTM. drape, polyurethane (PU)
drape such as one available from Avery Dennison Corporation of
Pasadena, Calif. An additional, specific non-limiting example of a
dressing sealing member material includes a 30 .mu.m matt
polyurethane film such as the Inspire.TM. 2317 manufactured by
Exopack.TM. Advanced Coatings of Matthews, N.C. The sealing member
114 may be preformed with an aperture or other means to transmit
fluid from the distribution manifold to the reduced-pressure
treatment unit 108. Alternatively, a healthcare provider may cut
the sealing member to form an aperture or a cutting element
attached to a reduced-pressure interface may be used to form an
aperture.
[0039] An attachment device 138 may be used to hold the sealing
member 114 against a portion of the patient's intact epidermis 126
or another layer, such as a gasket or additional sealing member.
The attachment device 138 may take numerous forms. For example, the
attachment device 138 may be a medically acceptable adhesive, such
as a pressure-sensitive adhesive, that extends about a periphery or
all of the sealing member 114. The attachment device 138 may also
be a sealing ring or other device. The attachment device 138 is
disposed on the second, tissue-facing side 136 of the sealing
member 114. Before use, the attachment device 138 may be covered by
a release liner (not shown).
[0040] The reduced-pressure interface 116 may be positioned
adjacent to or coupled to the sealing member 114 to provide fluid
access to the distribution manifold 112. Another attachment device
152 similar to the attachment device 138 may be used to hold the
reduced-pressure interface 116 against the sealing member 114. The
multi-lumen conduit 110 fluidly couples the reduced-pressure
treatment unit 108 and the reduced-pressure interface 116. The
reduced-pressure interface 116 allows the reduced pressure to be
delivered to the tissue site 102. While the amount and nature of
reduced pressure applied to a tissue site will typically vary
according to the application, the reduced pressure will typically
be between -5 mm Hg (-667 Pa) and -500 mm Hg (-66.7 kPa) and more
typically between -75 mm Hg (-9.9 kPa) and -300 mm Hg (-39.9 kPa).
For example, and not by way of limitation, the pressure may be -12,
-12.5, -13, -14, -14.5, -15, -15.5, -16, -16.5, -17, -17.5, -18,
-18.5, -19, -19.5, -20, -20.5, -21, -21.5, -22, -22.5, -23, -23.5,
-24, -24.5, -25, -25.5, -26, -26.5 kPa or another pressure.
[0041] As shown, the multi-lumen conduit 110 includes the primary
lumen 120 and the plurality of sensing lumens 122. In one
illustrative embodiment, the primary lumen 120 is a central lumen
140 and the plurality of sensing lumens 122 are peripheral lumens
142. The primary lumen 120 and the plurality of sensing lumens 122
are adapted to maintain fluid isolation between the primary lumen
120 and the plurality of sensing lumens 122 as the multi-lumen
conduit 110 transports fluids from the reduced-pressure interface
116 to the reduced-pressure treatment unit 108. Liquids or exudates
communicated from the distribution manifold 112 through the primary
lumen 120 are removed from the multi-lumen conduit 110 and retained
within a liquid-collection chamber (not explicitly shown) in fluid
communication with the reduced-pressure treatment unit 108. The
plurality of sensing lumens 122 fluidly communicates reduced
pressure representative of the tissue site 102 to an
instrumentation unit 144.
[0042] The reduced-pressure treatment unit 108 may include a
liquid-collection chamber, or a collection canister, and the
instrumentation unit 144 in fluid communication with a
reduced-pressure source 146. The instrumentation unit 144 may
include a microprocessor 148 adapted to process pressure signals
received by the multi-lumen conduit 110, monitor the pressure
signals, and issue alerts according to a pre-determined pressure
configuration.
[0043] In an illustrative embodiment, the reduced-pressure source
146 is an electrically-driven vacuum pump. In another
implementation, the reduced-pressure source 146 may instead be a
manually-actuated or manually-charged pump that does not require
electrical power. The reduced-pressure source 146 instead may be
any other type of reduced pressure pump, or alternatively a wall
suction port such as those available in hospitals and other medical
facilities. The reduced-pressure source 146 may be housed within or
used in conjunction with the reduced-pressure treatment unit 108,
which may also include the instrumentation unit 144. The
instrumentation unit 144 may include sensors, processing units,
alarm indicators, memory, databases, software, display units, and
user interfaces that further facilitate the application of reduced
pressure treatment to the tissue site 102.
[0044] In one example, pressure-detection sensors (not shown)
located in the instrumentation unit 144 may be disposed at or near
the reduced-pressure source 146. The pressure-detection sensors may
receive pressure data, or a pressure signal, from the
reduced-pressure interface 116 via at least one of the plurality of
sensing lumens 122 that is dedicated to delivering reduced pressure
data to the pressure-detection sensors. The pressure signal or data
may be representative of a pressure at a distal end 150 of any one
of the plurality of sensing lumens 122. The pressure-detection
sensors may communicate with a processing unit that monitors and
controls the reduced pressure that is delivered by the
reduced-pressure source 146.
[0045] Referring now primarily to FIG. 3A-3B, an illustrative
embodiment of the reduced pressure interface 116 is presented in
more detail. The reduced-pressure interface 116 includes a housing
154, a conduit port 156 coupled to the housing 154, the attachment
device 152 for coupling the reduced-pressure interface 116 to the
sealing member 114, and the multi-lumen conduit 110.
[0046] The housing 154 may have a flange portion 160 and a cavity
wall portion 162. The cavity wall portion 162 forms a cavity 164
having a tissue-facing cavity opening 166. The conduit port 156 is
coupled to or formed as part of the cavity wall portion 162 of the
housing 154. The conduit port 156 includes a conduit aperture 168
whereby the conduit port 156 is adapted to receive the multi-lumen
conduit 110. The attachment device 152 may be coupled to a
tissue-facing side 170 of the flange portion 160 for coupling the
housing 154 to the first side 134 of the sealing member 114. The
housing 154 is made of a semi-rigid material that is capable of
collapsing under a force such as a driving force 172. In a
non-limiting example, the reduced-pressure interface 116, and thus
the housing 154, may be made from a plasticized polyvinyl chloride
(PVC), polyurethane, cyclic olefin copolymer elastomer,
thermoplastic elastomer, poly acrylic, silicone polymer, and
polyether block amide copolymer.
[0047] The multi-lumen conduit 110 includes the distal end 118 and
a proximal end 158. The distal end 118 extends through the conduit
aperture 168 and past the cavity wall portion 162 into the cavity
164. In one specific, non-limiting embodiment, the distal end 118
extends past the cavity wall portion 162 up to 5 mm. It should be
understood, however, that the distal end 1118 may extend past the
cavity wall portion 162 beyond 5 mm. The extent to which the distal
end 118 extends past the cavity wall portion 162 may be determined
based on the housing's 154 ability to collapse under the driving
force 172. The proximal end 158 of the multi-lumen conduit 110
connects to the reduced-pressure treatment unit 108. In one
embodiment, the multi-lumen conduit 110 is connected to the conduit
port 156. The multi-lumen conduit 110 may be connected to the
conduit port 156 by a weld or adhesive. While the multi-lumen
conduit 110 is shown as extending past the cavity wall portion 162,
the multi-lumen conduit 110 may be flush with the cavity wall
portion 162 (not shown). The multi-lumen conduit 110 is adapted for
at least a portion of the distal end 118 of the multi-lumen conduit
110 to contact the distribution manifold 112 during reduced
pressure therapy. In one embodiment, a distal aperture 174 of the
primary lumen 120 and a distal aperture 176 of at least one of the
plurality of sensing lumens 122 is adapted to contact the
distribution manifold 112.
[0048] In operation, a method for treating the tissue site 102 on
the patient 104 with reduced pressure includes disposing the
distribution manifold 112 proximate to the tissue site 102. The
distribution manifold 112 and the portion of intact epidermis 126
of the patient 104 is covered with the sealing member 114 to form
the sealed space 132 in which the distribution manifold 112 is
disposed. The sealing member 114 has the first side 134 and the
second, tissue-facing side 136. The reduced-pressure interface 116
is coupled proximate the first side 134 of the sealing member 114.
The multi-lumen conduit 110 couples the reduced-pressure interface
116 to the reduced-pressure source 146. The reduced-pressure
interface 116 includes the housing 154 having the flange portion
160 and the cavity wall portion 162, such that the cavity wall
portion 162 forms the cavity 164 having the tissue-facing cavity
opening 166. The attachment device 138 coupled to the tissue-facing
side 170 of the flange portion 160 of the housing 154 connects the
housing 154 to the sealing member 114. The reduced-pressure
interface 116 further includes the conduit port 156 coupled to the
cavity wall portion 162 having the conduit aperture 168 for
receiving and coupling to the multi-lumen conduit 110. The
multi-lumen conduit 110 includes the distal end 118 and the
proximal end 158. The distal end 118 extends through the conduit
aperture 168 and past the cavity wall portion 162 into the cavity
164. The multi-lumen conduit 110 further includes the primary lumen
120 for delivering reduced pressure and the plurality of sensing
lumens 122. The primary lumen 120 and the plurality of sensing
lumens 122 extend from the proximal end 158 of the multi-lumen
conduit 110 to the distal end 118. At least a portion of the distal
end 118 of the multi-lumen conduit 110 is positioned in contact
with the distribution manifold 112.
[0049] The multi-lumen conduit 110 is connected to the conduit port
156. In one embodiment, the multi-lumen conduit 110 is welded to
the conduit port 156 prior to packaging. In another embodiment, the
multi-lumen conduit 110 is attached to the conduit port 156 by an
adhesive.
[0050] An aperture is formed in the sealing member 114 for
providing fluid communication between the housing 154 and the
distribution manifold 112. The aperture may be preformed, formed by
a healthcare provider, or formed by a cutting element on the
reduced-pressure interface 116.
[0051] The step of coupling the reduced-pressure interface 116
proximate to the first side 134 of the sealing member 114 may
include using the attachment device 152 of the reduced-pressure
interface 116 to adhere the reduced-pressure interface 116 to the
sealing member 114.
[0052] The step of positioning at least a portion of the distal end
118 of the multi-lumen conduit 110 in contact with the distribution
manifold 112 may further include positioning the distal aperture
174 of the primary lumen 120 and the distal aperture 176 of at
least one of the plurality of sensing lumens 122 in contact with
the distribution manifold 112. In one embodiment, the distal
aperture 176 of the at least one of the plurality of sensing lumens
122 is positioned below the distal aperture 174 of the primary
lumen 120 relative to the distribution manifold 112.
[0053] In another embodiment, the step of positioning the at least
the portion of the distal end 118 of the multi-lumen conduit 110 in
contact with the distribution manifold 112 further includes
applying the driving force 172 to the reduced-pressure interface
116 of sufficient strength to cause the at least the portion of the
distal end 118 of the multi-lumen conduit 110 to contact the
distribution manifold 112. The driving force 172 may push the
multi-lumen conduit 110 into the distribution manifold 112. In one
embodiment the driving force 172 may pull the distribution manifold
112 into the multi-lumen conduit 110. In yet another embodiment,
the driving force 172 may both push the multi-lumen conduit 110
into the distribution manifold 112 while pulling the distribution
manifold 112 into the multi-lumen conduit 110.
[0054] The step of positioning the at least the portion of the
distal end 118 of the multi-lumen conduit 110 in contact with the
distribution manifold 112 may further comprise applying a reduced
pressure.
[0055] In one embodiment, the step of positioning the at least the
portion of the distal end 118 of the multi-lumen conduit 110 in
contact with the distribution manifold 112 further comprises
applying reduced pressure through the reduced-pressure interface
116 to create sufficient reduced pressure in the cavity 164 to pull
a portion of the distribution manifold 112 into the cavity 164 such
that the distribution manifold 112 abuts the distal aperture 174 of
the primary lumen 120.
[0056] In another embodiment, the step of positioning the at least
the portion of the distal end 118 of the multi-lumen conduit 110 in
contact with the distribution manifold 112 further comprises the
step of applying reduced pressure through the reduced-pressure
interface 116 to create sufficient reduced pressure in the cavity
164 to push the housing 154 towards the distribution manifold 112
such that the distal aperture 174 of the primary lumen 120 and the
distal aperture 176 of the at least one of the sensory lumens 122
abuts the distribution manifold 112.
[0057] In yet another embodiment, the step of positioning the at
least the portion of the distal end 118 of the multi-lumen conduit
110 in contact with the distribution manifold 112 further comprises
manually applying the driving force 172 to an exterior of the
reduced-pressure interface 116.
[0058] In one embodiment, the step of applying the driving force
172 to the reduced-pressure interface 116 comprising applying
reduced pressure to the cavity 164 less than the threshold pressure
(P.sub.t) such that the wall portion collapses driving the
multi-lumen conduit 110 into the distribution manifold 112.
[0059] Referring now primarily to FIGS. 4-5B, another illustrative
embodiment of a reduced-pressure interface 216 is presented. The
reduced-pressure interface 216 is analogous in many respects to the
reduced-pressure interface of FIGS. 3A-3B. The reduced-pressure
interface 216 includes a housing 254 that may have a flange portion
260 and a cavity wall portion 262. The flange portion 260 may be
coupled to the sealing member 114 by the attachment device 152. The
cavity wall portion 262 is collapsible under reduced pressure. In
one embodiment, the cavity wall portion 262 is collapsible under
manual pressure. The cavity wall portion 262 may include a bellows
configuration 290 for permitting the cavity wall portion 262 to
collapse when a cavity 264 pressure (P.sub.c) inside the cavity 264
is less than a threshold pressure (P.sub.t) on an absolute pressure
side.
[0060] The reduced-pressure interface 216 may further include a
conduit adapter 292 for receiving the multi-lumen conduit 110 to
provide fluid communication between the reduced-pressure treatment
unit 108 and the tissue site 102. The conduit adapter 292 includes
an adapter flange 294. The adapter flange 294 is positioned on an
exterior 284 of the cavity wall portion 262. In a specific,
non-limiting example, the conduit adapter 292 and the adapter
flange 294 may be formed from materials to include plasticized
polyvinyl chloride (PVC), polyurethane, cyclic olefin copolymer
elastomer, thermoplastic elastomer, poly acrylic, silicone polymer,
and polyether block amide copolymer.
[0061] The multi-lumen conduit 110 is connected to the conduit
adapter 292. In a specific, non-limiting embodiment, the
multi-lumen conduit 110 may be connected to the conduit adapter 292
by a weld or an adhesive. The multi-lumen conduit 110 extends
beyond the conduit adapter 292 into the cavity 264. The
reduced-pressure interface 216 is configured to position the distal
end 118 of the multi-lumen conduit 110 in contact with the
distribution manifold 112.
[0062] In one embodiment, reduced pressure applied through the
reduced-pressure interface 216 may create sufficient reduced
pressure in the cavity 264 to pull a portion of the distribution
manifold 112 into the cavity 264 and abut the primary lumen 120 of
the multi-lumen conduit 110. In another embodiment, the
distribution manifold 112 may be partially pulled into the primary
lumen 120. The distribution manifold 112 abuts the distal end 118
of the multi-lumen conduit 110 including the distal aperture 176 of
the at least one of the plurality of sensing lumens 122. Allowing
the distribution manifold 112 to completely abut the distal end 118
of the multi-lumen conduit 110 may help ensure fluid isolation
between each of the lumens in the multi-lumen conduit 110.
[0063] Referring now primarily to FIGS. 6-7C, another illustrative
embodiment of a reduced-pressure interface 316 is presented. The
reduced-pressure interface 316 is analogous in many respects to the
reduced-pressure interface of FIGS. 3A-3B. The reduced-pressure
interface 316 includes a housing 354, a conduit port 356 coupled to
the housing 354, and the attachment device 152 for coupling the
reduced-pressure interface 316 to the sealing member 114. The
reduced-pressure interface 316 further includes a cutting element
317.
[0064] The housing 354 may have a flange portion 360 and a cavity
wall portion 362. The cavity wall portion 362 forms a cavity 364
having a tissue-facing cavity opening 366. The conduit port 356 is
coupled to or formed as part of the cavity wall portion 362 of the
housing 354. The conduit port 356 includes a conduit aperture 368
whereby the conduit port 356 is adapted to receive the multi-lumen
conduit 110. The attachment device 152 may be coupled to a
tissue-facing side 370 of the flange portion 360 for coupling the
housing 354 to the first side 134 of the sealing member 114. The
housing 354 is made of a semi-rigid material that is capable of
collapsing under a force such as the driving force 172. In a
non-limiting example, the reduced-pressure interface 316, and thus
the housing 354, may be made from a plasticized polyvinyl chloride
(PVC), polyurethane, cyclic olefin copolymer elastomer,
thermoplastic elastomer, poly acrylic, silicone polymer, and
polyether block amide copolymer.
[0065] The cutting element 317 may be at least temporarily coupled
to the housing 354 proximate to the tissue-facing cavity opening
366. The cutting element 317 is adapted to form an aperture 319 in
the sealing member 114 when the cutting element 317 is driven into
the sealing member 114 with the driving force 172. The driving
force 172 may also cause the cutting element 317 to penetrate or
cut a portion of the distribution manifold 112.
[0066] The cutting element 317 may have a piercing length
(L.sub.p). The distribution manifold 112 may have a thickness
greater than T when subject to reduced pressure such that the
piercing length (L.sub.p) of the cutting element 317 is less than
the thickness T, i.e., L.sub.p<T. One benefit of the piercing
length (L.sub.p) being less than the thickness, T, of the
distribution manifold 112 under reduced pressure is that the
cutting element 317 cannot completely cut through the distribution
manifold 112 and reach the tissue site 102.
[0067] As previously mentioned, the cutting element 317 may be only
temporarily coupled to the housing 354. In one embodiment, the
cutting element 317 may be removed by a care giver. In another
embodiment, the cutting element 317 may be formed from a liquid
soluble material such as a water soluble material adapted to allow
the cutting element 317 to dissolve. For example, the water soluble
material may include at least one of the following: Polyvinyl
alcohol (PVOH), polyvinyl pyrrolidone, hydroxyl and carboxyl
modified cellulose, hydroxyl and carboxyl modified acrylics,
starch, sugars (sucrose, glucose, fructose), weak acids (tartaric,
citric, malic), salts (sodium chloride, sodium carbonate, sodium
bicarbonate), polyethylene oxide (PEO), polyethylene glycol (PEG).
The cutting element 317 may dissolve as liquids are removed from
the tissue site 102. Reduced pressure is applied to the
reduced-pressure interface 316 after perforating the sealing member
114 typically causing liquids to be removed from the tissue site
102. After a sufficient amount of time, liquids removed from the
tissue site 102 cause the cutting element 317 to substantially
dissolve. The cutting element 317 may dissolve within 2 minutes, 5
minutes, 10 minutes, or another time period. As the cutting element
317 is dissolved the cutting element 317 is removed by the
multi-lumen conduit 110 with liquids from the tissue site 102. A
liquid, e.g., saline solution, may also be introduced through the
multi-lumen conduit 110, or otherwise, to dissolve the cutting
element 317.
[0068] As shown in FIG. 7C, once the cutting element 317 has
substantially dissolved, reduced pressure applied through the
reduced-pressure interface 316 creates sufficient reduced pressure
in the cavity 364 to pull a portion of the distribution manifold
112 into the cavity 364 such that the distribution manifold 112
abuts a distal end 118 of the multi-lumen conduit 110 to include
the distal aperture 176 of the at least one of the plurality of
sensing lumens 122. Allowing the distribution manifold 112 to
completely abut the distal end 118 of the multi-lumen conduit 110
may help ensure fluid isolation between each of the lumens in the
multi-lumen conduit 110.
[0069] In operation, a caregiver may treat the tissue site 102 on
the patient 104 with a method that includes disposing the
distribution manifold 112 proximate to the tissue site 102. The
distribution manifold 112 and the portion of intact epidermis 126
of the patient 104 is covered with the sealing member 114 to form
the sealed space 132 in which the distribution manifold 112 is
disposed. The reduced-pressure interface 316 is coupled to the
sealing member 114. The multi-lumen conduit 110 is fluidly coupled
on one end to the reduced-pressure source 146 and on the opposing
end to the reduced-pressure interface 316. The driving force 172 is
then applied to the reduced-pressure interface 316 with sufficient
strength to cause the cutting element 317 to perforate (e.g.,
pierce, tear, cut or otherwise create the aperture 319) the sealing
member 114.
[0070] Referring now primarily to FIGS. 8-9C, another illustrative
embodiment of a reduced-pressure interface 416 is presented. The
reduced-pressure interface 416 is analogous in many respects to the
reduced-pressure interface 316 of FIGS. 5A and 5B. The
reduced-pressure interface 416 includes a housing 454 and a cutting
element 417. The housing 454 may have a flange portion 460 and a
cavity wall portion 462. The flange portion 460 may be coupled to
the sealing member 114 by the attachment device 152. The cavity
wall portion 462 is collapsible under reduced pressure. The cavity
wall portion 462 may include a bellows configuration 490 for
permitting the cavity wall portion 462 to collapse when a cavity
pressure (P.sub.c) inside a cavity 464 is less than a threshold
pressure (P.sub.t) on an absolute pressure side.
[0071] The reduced-pressure interface 416 may further include a
conduit adapter 492 for receiving the multi-lumen conduit 110 to
provide fluid communication between the reduced-pressure treatment
unit 108 and the tissue site 102. The conduit adapter 492 includes
an adapter flange 494. The adapter flange 494 is positioned on an
exterior 484 of the cavity wall portion 462. In a specific,
non-limiting example, the conduit adapter 492 and the adapter
flange 494 may be formed from materials to include plasticized
polyvinyl chloride (PVC), polyurethane, cyclic olefin copolymer
elastomer, thermoplastic elastomer, poly acrylic, silicone polymer,
and polyether block amide copolymer.
[0072] The multi-lumen conduit 110 is connected to the conduit
adapter 492. In a specific, non-limiting embodiment, the
multi-lumen conduit 110 may be connected to the conduit adapter 492
by a weld or an adhesive. The multi-lumen conduit 110 extends
beyond the conduit adapter 492 into the cavity 464. The
reduced-pressure interface 416 is configured to position the distal
end 118 of the multi-lumen conduit 110 in contact with the
distribution manifold 112.
[0073] The cutting element 417 may be at least temporarily coupled
to the conduit adapter 492. The cutting element 417 is configured
to make orthogonal cuts in the sealing member 114 when the housing
454 is compressed with the driving force 172 thereby impacting the
cutting element 417. The cutting element 417 is thus driven into
the sealing member 114. The driving force 172 may be manually
applied to the exterior 484 of the reduced-pressure interface 416
causing the housing 454 to collapse and thereby driving or pushing
the cutting element 417 into the sealing member 114. In another
embodiment, the driving force 172 is applied by applying reduced
pressure to the cavity 464 such that the cavity pressure (P.sub.c)
in the cavity 464 is less than a threshold pressure (P.sub.t). When
the cavity pressure (P.sub.c) in the cavity 464 is less than the
threshold pressure (P.sub.t), the cavity wall portion 462 collapses
and impacts the cutting element 417. With continued reduced
pressure, a portion of the cutting element 417 is driven through
the sealing member 114. The threshold pressure (P.sub.t) is at
least in part dependent on the type and thickness of material used
for the housing 454. In the event reduced pressure is applied to
the cavity 464, a tensile force 473 may be applied to the sealing
member 114 causing the sealing member 114 to be pulled into the
cavity 464. This movement helps the cutting element 417 to be
driven into the sealing member 114.
[0074] In one embodiment, the cutting element 417 may be formed
from a liquid soluble material such as a water soluble material
adapted to allow the cutting element 417 to dissolve. The water
soluble material may include at least one of the following:
Polyvinyl alcohol (PVOH), polyvinyl pyrrolidone, hydroxyl and
carboxyl modified cellulose, hydroxyl and carboxyl modified
acrylics, starch, sugars (sucrose, glucose, fructose), weak acids
(tartaric, citric, malic), salts (sodium chloride, sodium
carbonate, sodium bicarbonate), polyethylene oxide (PEO),
polyethylene glycol (PEG). The cutting element 417 may dissolve as
liquids are removed from the tissue site 102. Reduced pressure is
applied to the reduced-pressure interface 416 typically causing
liquids to be removed from the tissue site 102. After a sufficient
amount of time, liquids removed from the tissue site 102 may cause
the cutting element 417 to substantially dissolve. As the cutting
element 417 is dissolved, the cutting element 417 is removed by the
multi-lumen conduit 110 with the liquids from the tissue site 102.
While the cutting element 417 may be dissolvable, it is worth
noting that the conduit adapter 492 and the adapter flange 494 do
not dissolve.
[0075] Once the cutting element 417 has substantially dissolved,
reduced pressure applied through the reduced-pressure interface 416
may be of sufficient reduced pressure in the cavity 464 to pull a
portion of the distribution manifold 112 into the cavity 464 and
into contact with the primary lumen 120 of the multi-lumen conduit
110. The distribution manifold 112 abuts the distal end 118 of the
multi-lumen conduit 110 including the distal aperture 176 of the at
least one of the plurality of sensing lumens 122. Allowing the
distribution manifold 112 to completely abut the distal end 118 of
the multi-lumen conduit 110 may help ensure fluid isolation between
each of the lumens in the multi-lumen conduit 110.
[0076] Although the present invention and its advantages have been
disclosed in the context of certain illustrative, non-limiting
embodiments, it should be understood that various changes,
substitutions, permutations, and alterations can be made without
departing from the scope of the invention as defined by the
appended claims. It will be appreciated that any feature that is
described in connection to any one embodiment may also be
applicable to any other embodiment.
[0077] It will be understood that the benefits and advantages
described above may relate to one embodiment or may relate to
several embodiments. It will further be understood that reference
to `an` item refers to one or more of those items.
[0078] The steps of the methods described herein may be carried out
in any suitable order, or simultaneously where appropriate.
[0079] Where appropriate, aspects of any of the examples described
above may be combined with aspects of any of the other examples
described to form further examples having comparable or different
properties and addressing the same or different problems. It will
be understood that the above description of preferred embodiments
is given by way of example only and that various modifications may
be made by those skilled in the art. The above specification,
examples and data provide a complete description of the structure
and use of exemplary embodiments of the invention. Although various
embodiments of the invention have been described above with a
certain degree of particularity, or with reference to one or more
individual embodiments, those skilled in the art could make
numerous alterations to the disclosed embodiments without departing
from the scope of the claims.
* * * * *